"O Hospital CUF Porto disponibiliza uma vasta oferta de cuidados de saúde para toda a família. Consulte os serviços e faça a sua marcação online."

During the past decade, Hospital CUF Porto; Servico de Imunoalergologia conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital CUF Porto; Servico de Imunoalergologia" are "Asthma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hospital CUF Porto; Servico de Imunoalergologia" in a lesser frequency.

Most popular intervention types in "Hospital CUF Porto; Servico de Imunoalergologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Lebrikizumab" (1 trials) and "Pemetrexed" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital CUF Porto; Servico de Imunoalergologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital CUF Porto; Servico de Imunoalergologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital CUF Porto; Servico de Imunoalergologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital CUF Porto; Servico de Imunoalergologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".